What is Amneal Pharmaceuticals, Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Amneal Pharmaceuticals, Inc.'s reported free cash flow gives $11.14 per share. The share price was $19.77 on September 25, 2026, 77% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 3.5% | 10.0% | $4.11 | -79% |
| Base | 8.5% | 9.0% | $11.14 | -44% |
| Bull | 13.5% | 8.0% | $25.17 | +27% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $16.41 | $18.02 | $19.99 | $22.46 | $25.63 |
| 8.0% | $12.47 | $13.52 | $14.76 | $16.24 | $18.06 |
| 9.0% | $9.60 | $10.32 | $11.14 | $12.11 | $13.25 |
| 10.0% | $7.42 | $7.92 | $8.50 | $9.16 | $9.92 |
| 11.0% | $5.70 | $6.07 | $6.49 | $6.96 | $7.49 |
Where the presets come from
Base: years 1 to 5 grow at Amneal Pharmaceuticals, Inc.'s revenue growth rate over the last 5 fiscal years (8.7% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions